Delivery Order SPE2DB25D3201-SPE2DB25FNWPG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 mL unit doses totaling 20,000 units. The contract, awarded on September 16, 2025, with an ultimate completion date of October 7, 2025, utilizes firm fixed pricing under a non-competitive delivery order structure. This order will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,225.29 delivery order to AmerisourceBergen Drug Corp for PHESGO (pertuzumab, trastuzumab, and hyaluronidase-oysk), a specialty pharmaceutical product used in cancer treatment. The delivery order, issued on August 6, 2025, calls for 30,000 units of the 1,200-600 mg/15mL formulation with an ultimate completion date of August 27, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $5,458.39 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 mg in 10ml vials, with a completion deadline of September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of PHESGO 600-600 MG pharmaceutical product (20,000 units of 10ML vials) with an ultimate completion date of October 14, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $32,750.34 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 26, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10ML vials. This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, issued on September 2, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a $10,916.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 units of PHESGO 600-600 MG in 10 mL vials. This is an unset-aside, competitively awarded contract with a completion date of June 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a $10,916.78 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of PHESGO 600-600 mg pharmaceutical product in 20,000 units of 10ml vials. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a non-competitive, non-set-aside award to support federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products, with an order quantity of 20,000 units in 10ML vials. The contract is a firm fixed price delivery order with no set-aside designation, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNWPGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,833.56 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of PHESGO (pertuzumab, trastuzumab, and hyaluronidase) 600-600 mg in 10 ml units, totaling 20,000 units with delivery completion by October 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical prime vendor contract running through December 2026 that supports military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial portfolio of federal medical procurement contracts with DLA and other government healthcare systems. The company's role as a critical vendor for federal medical supply chains includes distribution of specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This particular delivery order for PHESGO, a specialty oncology treatment, exemplifies the company's capability to fulfill federal procurement requirements for specialized pharmaceutical products within compressed timeframes while maintaining competitive pricing through established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 9/16/25 |